| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Jack Nielsen last filed a Form 4 in May 2024, as Director at TIL. The filings on record cover 3 companies. From August 2020 to December 2022, the filings on record show 4 open-market purchases and 22 sales. Jack Nielsen's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Our model assigns Jack Nielsen a strong insider score of 76/100, based on 53 past trades. Over a 12-month horizon, 96.2% of those trades were profitable, with an average 12-month return of +33.4%.
At the last filing, the largest reported position was 2,571,024 shares of HRMY. The HRMY filings lean toward selling, a net 1,729,242 shares.
Shares as reported in the last Form 4 for each company; the most recent is from May 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 24, 2022 | HRMY Harmony Biosciences Holdings, Inc. | Director | Sell | 36,294 | $50.16 | $1,820,522.83 | -0.8% | -4.7% | -16.9% | |
| Mar 18, 2022 | HRMY Harmony Biosciences Holdings, Inc. | Director | Sell | 16,181 | $50.08 | $810,373.30 | -0.4% | -13.6% | -14.7% | |
| Nov 9, 2021 | IOBT Io Biotech, Inc. | Director | Buy | 650,000 | $14.00 | $9,100,000.00 | +27.5% | -36.9% | -81.2% | |
| Mar 23, 2021 | TIL Instil Bio, Inc. | Director | Buy | 300,000 | $20.00 | $6,000,000.00 | +2.5% | -28.9% | -58.7% | |
| Aug 26, 2020 | HRMY Harmony Biosciences Holdings, Inc. | Director | Buy | 4,745 | $34.28 | $162,671.20 | +12.5% | - | - | |
| Aug 24, 2020 | HRMY Harmony Biosciences Holdings, Inc. | Director | Buy | 37,957 | $27.58 | $1,046,806.30 | New | - | - |